ArticleJournal of the American Geriatrics Society2016
Racial and Ethnic Differences in Initiation and Discontinuation of Antidementia Drugs by Medicare Beneficiaries.
Article in Journal of the American Geriatrics Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Access to healthcare services and adherence to treatments for people with dementia among ethnic minority groups: a scoping review.Frontiers in dementia · 2026Pooled it
- Persistence with anti-dementia medications: a systematic review and meta-analysis.Age and ageing · 2025Pooled it
- Sociodemographic differences in discontinuation of high-risk medications: a retrospective cohort study.npj aging · 2025Article
- Pharmacoequity measurement framework: A tool to reduce health disparities.Journal of managed care & specialty pharmacy · 2025Article
- Emergency Medical Services Provider-Perceived Alzheimer's Disease and Related Dementias in the Prehospital Setting.The western journal of emergency medicine · 2025Article
- Inequalities in the Quality and Safety of Post-Diagnostic Primary Care for People With Dementia: A Scoping Review.International journal of geriatric psychiatry · 2024Article
- Mapping racial and ethnic healthcare disparities for persons living with dementia: A scoping review.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024Article
- An outcome-wide analysis of the effects of diagnostic labeling of Alzheimer's disease and related dementias on social relationships.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024Article
- Effects of Medicare Part D medication therapy management on racial/ethnic disparities in adherence to antidementia medications among patients with Alzheimer's disease and related dementias: An observational study.Exploratory research in clinical and social pharmacy · 2024Article
- Quantification of race/ethnicity representation in Alzheimer's disease neuroimaging research in the USA: a systematic review.Communications medicine · 2023Review
- Alzheimer's disease medication use and adherence patterns by race and ethnicity.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023Article
- Short-term associations between warm-season ambient temperature and emergency department visits for Alzheimer's disease and related dementia in five US states.Environmental research · 2023Article
- Specialist Availability and Drug Adherence in Older Adults with Dementia Across Regions of the United States.Journal of Alzheimer's disease : JAD · 2023Article
- Racial/ethnic disparities in initiation and persistent use of anti-dementia medications.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2022Article
- An HIT-Supported Care Coordination Framework for Reducing Structural Racism and Discrimination for Patients With ADRD.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2022Review
- Article
- The Cultural Diversity of Dementia Patients and Caregivers in Primary Care Case Management: a Pilot Mixed Methods Study.Canadian geriatrics journal : CGJ · 2021Article
- Impact of dementia: Health disparities, population trends, care interventions, and economic costs.Journal of the American Geriatrics Society · 2021Review
- Aducanumab: Appropriate Use Recommendations.The journal of prevention of Alzheimer's disease · 2021Article
- Dementia Care in Diverse Older Adults in the U.S. Deep South and the Rest of the United States.Journal of Alzheimer's disease : JAD · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectivesTo examine racial and ethnic differences in initiation and time to discontinuation of antidementia medication in Medicare beneficiaries.
designRetrospective cohort study.
settingSecondary analysis of 2009-10 enrollment, claims, and Part D prescription data for a 10% national sample of U.S. Medicare fee-for-service beneficiaries.
participantsBeneficiaries aged 65 and older with Alzheimer's disease or related dementia (ADRD) before 2009 and no fills for antidementia medications in the first half of 2009 (N = 84,043). MEASUREMENTS: Initiation was defined as having one or more fills for antidementia medication in the second half of 2009 and discontinuation as a gap in coverage of 30 days or more during the year after initiation. The Andersen Behavioral Model was used to guide covariate selection.
resultsOverall, 3,481 (4.1%) of previous nonusers initiated antidementia medication in the second half of 2009. Of those initiating one drug class (acetylcholinesterase inhibitors (AChEIs) or memantine), 9% later added the other class, and 2% switched classes. Of initiators, 23% discontinued within 1 month, and 62% discontinued within 1 year. Hispanic beneficiaries were more likely than white beneficiaries to initiate (adjusted odds ratio = 1.25, 95% confidence interval (CI) = 1.10-1.41). Black and white beneficiaries did not differ in likelihood of initiation. Hispanic (adjusted hazard ratio (aHR) = 1.56, 95% CI = 1.34-1.82) and black (aHR = 1.25, 95% CI = 1.08-1.44) beneficiaries discontinued at a faster rate than white beneficiaries.
conclusionInitiation of antidementia medications was no different in black and white beneficiaries and more likely in Hispanic beneficiaries; black and Hispanic beneficiaries discontinued at a faster rate. More research into reasons explaining these differences is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.